Spiriva Capsules ; Out-of-specification (uniformity of delivered dose)
Brand(s)
Last updated
Summary
Product
Spiriva 18mcg capsule
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot Number |
|---|---|---|---|---|---|
| Boehringer Ingelheim Canada Ltd. | Spiriva 18mcg capsule | DIN 02246793 | Capsule | Tiotropium bromide monohydrate 18mcg | 405636 |
Issue
The affected lot may not consistently provide the intended dose of medication with each use.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Wholesalers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Boehringer Ingelheim Canada Ltd.
5180 South Service Road,
Burlington ON, L7L 5H4 Canada
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Identification number
RA-82251
Get notified
Receive emails about new and updated recall and safety alerts.